Human anti-pig cell-mediated cytotoxicity in vitro involves non-T as well as T cell components

Xenotransplantation

Volumn 3, Issue 1 PART 2, 1996, Pages 158-165

  Chan, Derek V ^a   Auchincloss Jr , Hugh ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cytotoxicity; Human PBLs; T cells

Indexed keywords

EID: 0001062057     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1996.tb00133.x     Document Type: Article

References (20)

1. MOSES RD, WINN HJ, AUCHINCLOSS HJ. Evidence that multiple defects in cell-surface molecule interactions across species differences are responsible for diminished xenogeneic T cell responses. Transplantation 1992:53:203-9.
2. HEISER A, ULRICHS K, ECKSTEIN V, MULLEr-RUCHOUTZ W. Xenogeneic cellular response of human lymphocytes to porcine lymphocytes and isolated porcine pancreatic islets. Transplant Proc 1992:24:2881-2882.
3. KIRK AD, LI RA, KINCH MS, ABERNETHY KA, DOYLE C, BOLLINGER RR. The human antiporcine cellular repertoire: In vitro studies of acquired and innate cellular responsiveness. Transplantation 1993:55:924-931.
4. MURRAY AG, KHODADOUST MM, POBER JS, BOTHWELL ALM. Porcine aortic endothelial cells activate human T cells: Direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994:1:57-63.
5. ROLLINS SA, KENNEDY SP, CHODERA AJ, ELLIOTT EA, ZAVOICO GB, MATIS LA. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2. Transplantation 1994:57:1709-1716.
6. KUMAGAI-BRAESCH M, SATAKE M, KORSGREN O, ANDERSSON A, MOLLER E. Characterization of cellular human anti-porcine xenoreactivity. Clin Transplantation 1993:7:273-280.
7. VALLEE I, WATIER H, THIBAULT G, SALMON H, GRUEL Y, LEBRANCHU Y, BARDOS P. Evidence of noninvolvement of swine MHC class II in the in vitro proliferative response of human lymphocytes to porcine endothelial cells. Transplantation 1995:59:897-901.
8. YAMADA K, SACHS DH, DERSIMONIAN H. Human anti-porcine xenogeneic T cell response: Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 1995:155:5249-5256.
9. BRAVERY CA, BATTEN P, YACOUB MH, ROSE ML. Direct recognition of SLA- and HLA-like class II antigens on porcine endothelium by human T cells results in T cell activation and release of interleukin-2. Transplantation 1995:60:1024-1033.
10. ELSEN M, SOARES M, LATINNE D, CORNET A, BAZIN H. Role of activated natural killer and CD4+, CD8+ cells in the cellular rejection of a discordant xenograft. Transplant Proc 1993:25:447-449.
11. SATAKE M, KURSGREN O, RIDDERSTAD A, KARLSSON-PARRA A, WALLGREN AC, MOLLER E. Immunological characteristics of islet cell xenotransplantation in humans and rodents. Immunol Rev 1994:141:191-211.
12. INVERARDI L, PARDI R. Humoral and cellular recognition of discordant xenogeneic Langerhans islets. Transplant Proc 1994:26:1034-36.
13. SACHS DH, LEIGHT G, CONE J, et. al. Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation 1976:22:559-567.
14. SCHAAPHERDER AFM, DAHA MR, TE BULTE M-J, VAN DER WOUDE FJ, GOOSZEN HG. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 1994:57:1376-1382.
15. SATAKE M, KUMAGI-GRAESCH M, KORSGREN O, ANDERSSON A, MOLLER E. Characterization of humoral human anti-porcine xenoreactivity. Clinical Transplantation 1993:7:281-288.
16. CORREA I, RAULET DH. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 1995:2:61-71.
17. WAGTMANN N, BIASSONI R, CANTONI C, VERDIANI S, MAINATI M, VITALE M, BOTTINO C, MORETTA L, MORETTA A, LONG EO. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995:2:439-449.
18. BEZOUSKA K, YUEN C, O'BRIAN J, CHILDS RA, CHAI W, LAWSON AM, DRBAL K, FISEROVA A, POSPISIL M, FEIZI T. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 1994:372:150-157.
19. RYAN JC, NIEME EC, NAKAMURA MC, SEAMAN WE. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J Exp Med 1995:181:1911-1915.
20. WAGTMANN N, RAJOGOPAIAN S, WINTER CC, PERUZZI M, LONG EO. Killer cell inhibitory receptors specific for HLA - C and HLA-B identified by direct binding and by functional transfer. Immunity 1995:3:801-809.